Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow fever vaccine immune response study in rural and urban Tanzania
PACTR202405738173023Completed
- Sponsor
- Kilimanjaro Christian Medical Centre
- Start
- Aug 2022
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Kilimanjaro Christian Medical Centre. Primary endpoint: Immune response. Started Aug 2022; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on PACTR202405738173023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405738173023.